Impact of Iron/Folic Acid vs Folic Acid Supplements During Pregnancy on Maternal and Child Health
NCT02221752 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2367
Last updated 2014-08-20
Summary
According to a national study in 2002, the prevalence of ID, IDA, and ID+IDA among pregnant women in China was 42.6%, 9.1%, and 61.7% respectively. A similar study in Hebei province at the same time showed that the prevalence of IDA among pregnant and lactating mothers was 46.39% and 47.21% respectively. There was a significant difference between urban and rural areas. Women living in rural areas had higher chances of having IDA (p\<0.01). WHO and UNICEF recommend taking iron, folic acid and multiple micronutrients during pregnancy. However, we don't know much about their influence on maternal and infant health and their clinical effectiveness. Health Department of China recommends taking 400ug folic acid before pregnancy and during early pregnancy. But for various reasons, not all expecting mothers take this advice. Besides, we don't have a national level technical standard of how to take nutrition supplements during pregnancy. Therefore, it's crucial for us to study if iron/folic acid or folic acid only can prevent perinatal complications, as well as their influences on infant and toddler health.
The purpose of this study is to test whether taking iron/folic acid and folic acid only from early pregnancy until delivery will lower the chances of pregnancy complications, and to see how supplements affect gestation results. As well, it will evaluate a) whether taking iron supplement during pregnancy can prevent IDA during pregnancy; b) whether taking iron supplement can increase mother and fetus iron storage; and c) how mother's iron level affects newborn's iron level. We hope to understand nutrition conditions during pregnancy and investigate the relations between pregnancy diet and complications during pregnancy, weight gain during pregnancy, and newborn birth weight. We will evaluate the influence of taking iron and folic acid during pregnancy on the health of infants and toddlers.
Conditions
Interventions
- DIETARY_SUPPLEMENT
-
Ferrous Sulfate + folic acid
Mothers randomized to receive 2 capsules per day: one with iron (300 mg ferrous sulfate \[60 mg elemental iron\]) and the other with 0.40 mg folic acid from enrollment to delivery.
- DIETARY_SUPPLEMENT
-
Folic acid
Mothers randomized to receive 2 capsules per day: one with placebo and one with 0.40 mg folic acid from enrollment to delivery.
Sponsors & Collaborators
-
Zhao gengli
lead OTHER -
Vifor Pharma
collaborator INDUSTRY
Principal Investigators
-
Zhao Gengli, MD · Peking University First Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-06-30
- Primary Completion
- 2011-12-31
- Completion
- 2011-12-31
Countries
- China
Study Locations
More Related Trials
-
Analysis of the Effect of Iron Supplements on Iron Deficiency Anemia in Pregnancy
NCT05804071 ·Status: UNKNOWN ·Phase: PHASE4
-
Treatment of Non-Anemic Iron Deficiency in Pregnancy
NCT05423249 ·Status: COMPLETED ·Phase: NA
-
Periconceptional Iron Supplementation in Rural Bangladesh
NCT00953134 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Trial of Pre-Pregnancy Supplements
NCT01183572 ·Status: COMPLETED ·Phase: NA
-
Iron Deficiency Anemia Among Chinese Pregnant Women: a Multi-center Prospective Cohort Study
NCT03961074 ·Status: COMPLETED
-
Lactoferrin Supplementation and Iron Metabolism in Healthy Pregnant Women
NCT03122938 ·Status: UNKNOWN ·Phase: NA
-
Daily vs Alternate Day Iron Supplementation for Pregnant Women With Iron Deficiency Anemia
NCT03562143 ·Status: COMPLETED ·Phase: NA
-
Oral Lactoferrin Versus Iron Supplementation During Pregnancy
NCT03542825 ·Status: COMPLETED ·Phase: PHASE4
-
Daily Versus Alternate Day Iron Supplementation for the Treatment of Iron Deficiency Anemia in Pregnancy
NCT04594070 ·Status: TERMINATED ·Phase: PHASE4
-
Healthy Infant Development Project
NCT00613717 ·Status: COMPLETED ·Phase: NA
-
Iron-fortified Lentils to Improve Iron (Fe) Status in Bangladesh
NCT03516734 ·Status: UNKNOWN ·Phase: NA
-
Effect of Antenatal Iron-contained Multiple Micronutrient Supplementation, Cesarean Delivery, and CDMR on Child Health
NCT01404416 ·Status: COMPLETED
-
Fermented Iron-rich Supplement in Reducing Anemia
NCT02037724 ·Status: UNKNOWN ·Phase: PHASE2
-
A Double-blind, Double-dummy, Parallel, Active-controlled, Randomized Trial to Evaluate Efficacy & Safety in Anemia Subjects
NCT01425463 ·Status: COMPLETED ·Phase: PHASE3
-
Ferrous Fumarate and Ferric Pyrophosphate as Food Fortificants in Developing Countries
NCT00867867 ·Status: COMPLETED ·Phase: PHASE1
-
Iron Bioavailability From Cubes
NCT02327299 ·Status: COMPLETED ·Phase: NA
-
Defining a Dosing Regimen With Maximal Absorption for Oral Iron Supplementation During Pregnancy
NCT04074707 ·Status: COMPLETED ·Phase: NA
-
Iron Bioavailability of High Surface Area Ferric Phosphate
NCT03660462 ·Status: COMPLETED ·Phase: NA
-
Effect of Rice Fortification With Iron on Anemia Among Children
NCT00727545 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Daily vs Intermittent Iron Therapy in Pregnancy
NCT03706638 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of the Treatment for Infant Iron Deficiency Anemia by Taking Lactoferrin and Ferralia
NCT03534089 ·Status: COMPLETED ·Phase: NA
-
the Efficacy and Safety of Vitamin C for Iron Supplementation in Adult IDA Patients
NCT02631668 ·Status: COMPLETED ·Phase: PHASE4
-
Multiple Micronutrient Supplementation (MMS) vs IFA Acceptability Crossover Trial
NCT06069856 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Peri-conception Key Nutritional Factors and Congenital Heart Disease
NCT02737644 ·Status: COMPLETED
-
Efficacy and Safety of Heme-Iron Polypeptide on Improvement of Anemia
NCT01733979 ·Status: COMPLETED ·Phase: NA